137 related articles for article (PubMed ID: 36683195)
1. Biased GLP-2 agonist with strong G protein-coupling but impaired arrestin recruitment and receptor desensitization enhances intestinal growth in mice.
Gabe MBN; von Voss L; Hunt JE; Gadgaard S; Gasbjerg LS; Holst JJ; Kissow H; Hartmann B; Rosenkilde MM
Br J Pharmacol; 2023 Jul; 180(13):1674-1689. PubMed ID: 36683195
[TBL] [Abstract][Full Text] [Related]
2. Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system.
Gadgaard S; Windeløv JA; Schiellerup SP; Holst JJ; Hartmann B; Rosenkilde MM
Biomed Pharmacother; 2023 Apr; 160():114383. PubMed ID: 36780786
[TBL] [Abstract][Full Text] [Related]
3. Abolishing β-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonists.
Hinds CE; Peace E; Chen S; Davies I; El Eid L; Tomas A; Tan T; Minnion J; Jones B; Bloom SR
Diabetes Obes Metab; 2024 Jan; 26(1):65-77. PubMed ID: 37795639
[TBL] [Abstract][Full Text] [Related]
4. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
Estall JL; Koehler JA; Yusta B; Drucker DJ
J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
[TBL] [Abstract][Full Text] [Related]
5. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
[TBL] [Abstract][Full Text] [Related]
6. The role of G protein-coupled receptor kinases in GLP-1R β-arrestin recruitment and internalisation.
McNeill SM; Lu J; Marion C Carino C; Inoue A; Zhao P; Sexton PM; Wootten D
Biochem Pharmacol; 2024 Apr; 222():116119. PubMed ID: 38461904
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of the extracellular surface residues of glucagon-like peptide-1 receptor in β-arrestin 1/2 signaling.
Lei S; Meng Q; Liu Y; Liu Q; Dai A; Cai X; Wang MW; Zhou Q; Zhou H; Yang D
Eur J Pharmacol; 2024 Apr; 968():176419. PubMed ID: 38360293
[TBL] [Abstract][Full Text] [Related]
8. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
[TBL] [Abstract][Full Text] [Related]
9. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.
Sonoda N; Imamura T; Yoshizaki T; Babendure JL; Lu JC; Olefsky JM
Proc Natl Acad Sci U S A; 2008 May; 105(18):6614-9. PubMed ID: 18445652
[TBL] [Abstract][Full Text] [Related]
10. β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues.
Hager MV; Johnson LM; Wootten D; Sexton PM; Gellman SH
J Am Chem Soc; 2016 Nov; 138(45):14970-14979. PubMed ID: 27813409
[TBL] [Abstract][Full Text] [Related]
11. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
Conroy JL; Free RB; Sibley DR
ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
[TBL] [Abstract][Full Text] [Related]
12. Characterization of structurally novel G protein biased CB
Ford BM; Franks LN; Tai S; Fantegrossi WE; Stahl EL; Berquist MD; Cabanlong CV; Wilson CD; Penthala NR; Crooks PA; Prather PL
Pharmacol Res; 2017 Nov; 125(Pt B):161-177. PubMed ID: 28838808
[TBL] [Abstract][Full Text] [Related]
13. Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s).
Jorgensen R; Kubale V; Vrecl M; Schwartz TW; Elling CE
J Pharmacol Exp Ther; 2007 Jul; 322(1):148-54. PubMed ID: 17395766
[TBL] [Abstract][Full Text] [Related]
14. Lipid raft-dependent glucagon-like peptide-2 receptor trafficking occurs independently of agonist-induced desensitization.
Estall JL; Yusta B; Drucker DJ
Mol Biol Cell; 2004 Aug; 15(8):3673-87. PubMed ID: 15169869
[TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
[TBL] [Abstract][Full Text] [Related]
16. β
De Pascali F; Ippolito M; Wolfe E; Komolov KE; Hopfinger N; Lemenze D; Kim N; Armen RS; An SS; Scott CP; Benovic JL
Br J Pharmacol; 2022 Oct; 179(19):4692-4708. PubMed ID: 35732075
[TBL] [Abstract][Full Text] [Related]
17. Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.
Bouma J; Soethoudt M; van Gils N; Xia L; van der Stelt M; Heitman LH
Methods Mol Biol; 2023; 2576():189-199. PubMed ID: 36152187
[TBL] [Abstract][Full Text] [Related]
18. Differential In Vitro Pharmacological Profiles of Structurally Diverse Nociceptin Receptor Agonists in Activating G Protein and Beta-Arrestin Signaling at the Human Nociceptin Opioid Receptor.
Lu JJ; Polgar WE; Mann A; Dasgupta P; Schulz S; Zaveri NT
Mol Pharmacol; 2021 Jul; 100(1):7-18. PubMed ID: 33958480
[TBL] [Abstract][Full Text] [Related]
19. Carfentanil is a β-arrestin-biased agonist at the μ opioid receptor.
Ramos-Gonzalez N; Groom S; Sutcliffe KJ; Bancroft S; Bailey CP; Sessions RB; Henderson G; Kelly E
Br J Pharmacol; 2023 Sep; 180(18):2341-2360. PubMed ID: 37005796
[TBL] [Abstract][Full Text] [Related]
20. Identification of a β-arrestin-biased negative allosteric modulator for the β
Ippolito M; De Pascali F; Hopfinger N; Komolov KE; Laurinavichyute D; Reddy PAN; Sakkal LA; Rajkowski KZ; Nayak AP; Lee J; Lee J; Cao G; Donover PS; Reichman M; An SS; Salvino JM; Penn RB; Armen RS; Scott CP; Benovic JL
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2302668120. PubMed ID: 37490535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
